Iatrogenic Creutzfeldt-Jakob disease

Handb Clin Neurol. 2018:153:207-218. doi: 10.1016/B978-0-444-63945-5.00012-X.

Abstract

Iatrogenic transmission of Creutzfeldt-Jakob disease (CJD) has occurred through particular medical procedures. Among them, dura mater grafts and pituitary-derived growth hormone obtained from human cadavers undiagnosed as CJD are the most frequent sources of infection. Recent advances in our knowledge about dura mater graft- and human pituitary-derived growth hormone-associated CJD patients have revealed that the combination of the infected CJD strain and the PRNP genotype of the patient determines their clinical, neuropathologic, and biochemical features. In this chapter, we summarize the clinical, neuropathologic, biochemical, and diagnostic features of dura mater graft- and human pituitary-derived growth hormone-associated CJD patients for the appropriate diagnosis of iatrogenic CJD.

Keywords: Creutzfeldt–Jakob disease; M1 strain; V2 strain; acquired; dura mater graft; human pituitary-derived growth hormone; iatrogenic.

MeSH terms

  • Brain / metabolism
  • Brain / pathology
  • Creutzfeldt-Jakob Syndrome* / diagnosis
  • Creutzfeldt-Jakob Syndrome* / genetics
  • Creutzfeldt-Jakob Syndrome* / physiopathology
  • Creutzfeldt-Jakob Syndrome* / transmission
  • Genotype
  • Human Growth Hormone / metabolism
  • Humans
  • Iatrogenic Disease*
  • Prion Proteins / genetics*
  • Prion Proteins / metabolism

Substances

  • Prion Proteins
  • Human Growth Hormone